Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- RSV Therapeutics LLC
- Target Recruit Count
- 274
- Registration Number
- NCT04940182
- Locations
- 🇷🇺
Municipal Budgetary Institution of Healthcare "Central City Hospital of Novoshakhtinsk", Novoshakhtinsk, Rostov Region, Russian Federation
🇷🇺LLC "Family Clinic", Ekaterinburg, Russian Federation
🇷🇺Regional Budgetary Institution of Healthcare "Ivanovskaya Clinical Hospital named after Kuvaevykh", Ivanovo, Russian Federation
A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- RSV Therapeutics LLC
- Target Recruit Count
- 118
- Registration Number
- NCT04487574
- Locations
- 🇷🇺
Municipal Budgetary Institution of Healthcare "Central City Hospital of Novoshakhtinsk", Novoshakhtinsk, Rostov Region, Russian Federation
🇷🇺Saint Petersburg State Budgetary Institution of Healthcare "City Hospital No. 40 of Kurortny District", Saint Petersburg, Russian Federation
🇷🇺Saint Petersburg State Budgetary Institution of Healthcare "City Pokrovskaya Hospital" (4th Cardiology Department), Saint Petersburg, Russian Federation